Factors affecting anxiety in multiple sclerosis

Disability and Rehabilitation

Volumn 34, Issue 24, 2012, Pages 2047-2052

  Garfield, A C ^a   Lincoln, N B ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Anxiety; Depression; Multiple sclerosis

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; DEPRESSION; DISABLED PERSON; FEMALE; HUMAN; MALE; MENTAL STRESS; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; REGRESSION ANALYSIS; RISK FACTOR; SELF CONCEPT; SEVERITY OF ILLNESS INDEX; UNITED KINGDOM;

ADULT; AGED; ANXIETY; COHORT STUDIES; DEPRESSION; DISABLED PERSONS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SELF EFFICACY; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL;

EID: 84867292410     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2012.667503     Document Type: Article

References (51)

1. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatr 2005;76:469-475.
2. Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007;13:67-72.
3. Janssens AC, van Doorn PA, de Boer JB, van der Meché FG, Passchier J, Hintzen RQ. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand 2003;108:389-395.
4. Feinstein A, O'Connor P, Gray T, Feinstein K. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler 1999;5:323-326.
5. Mitchell AJ, Benito-León J, González JM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 2005;4:556-566.
6. Mohr DC, Boudewyn AC, Likosky W, Levine E, Goodkin DE. Injectable medication for the treatment of multiple sclerosis: the influence of self-effcacy expectations and injection anxiety on adherence and ability to self-inject. Ann Behav Med 2001;23:125-132.
7. Sherbourne CD, Wells KB, Meredith LS, Jackson CA, Camp P. Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry 1996;53:889-895.
8. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 2001;7:340-344.
9. Goldman Consensus Group. The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 2005;11:328-337.
10. Minden SL. Mood disorders in multiple sclerosis: diagnosis and treatment. J Neurovirol 2000;6 Suppl 2:S160-S167.
11. Allen D, Landis R, Schramke C. The role of psychologists in the treatment of multiple sclerosis. Int J Rehabil Health 1995;1:97-123.
12. Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli R P, Cazzato G, Bratina A, Zivadinov R. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol 2001;248:416-421.
13. Janssens AC, Buljevac D, van Doorn PA, van der Meché FG, Polman CH, Passchier J, Hintzen RQ. Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study. Mult Scler 2006;12:794-801.
14. Forman AC, Lincoln NB. Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial. Clin Rehabil 2010;24:211-221.
15. Brown RF, Valpiani EM, Tennant CC, Dunn SM, Sharrock M, Hodgkinson S, Pollard JD. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol Psychother 2009;82:41-56.
16. Stenager E, Knudsen L, Jensen K. Multiple sclerosis: correlation of anxiety, physical impairment and cognitive dysfunction. Ital J Neurol Sci 1994;15:97-101.
17. Smith SJ, Young CA. The role of affect on the perception of disability in multiple sclerosis. Clin Rehabil 2000;14:50-54.
18. Lester K, Stepleman L, Hughes M. The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population. J Behav Med 2007;30:177-186.
19. Beiske AG, Svensson E, Sandanger I, Czujko B, Pedersen ED, Aarseth JH, Myhr KM. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 2008;15:239-245.
20. Brajkovic L, Bras M, Milunovic V, Busic I, Boban M, Loncar Z, Mickovic V, Gregurek R. The connection between coping mechanisms, depression, anxiety and fatigue in multiple sclerosis. Coll Antropol 2009;33 Suppl 2:135-140.
21. Thornton E W, Tedman S, Rigby S, Bashforth H, Young C. Worries and concerns of patients with multiple sclerosis: development of an assessment scale. Mult Scler 2006;12:196-203.
22. Airlie J, Baker GA, Smith SJ, Young CA. Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-effcacy scale. Clin Rehabil 2001;15:259-265.
23. Shelley M, Pakenham K. External health locus of control and general self-effcacy: moderators of emotional distress among university students. Aust J Psychol 2004;56:191-199.
24. Wassem R. A test of the relationship between health locus of control and the course of multiple sclerosis. Rehabil Nurs 1991;16: 189-193.
25. Brown RF, Tennant CC, Dunn SM, Pollard JD. A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables. Mult Scler 2005;11: 477-484.
26. Vuger-Kovacic D, Gregurek R, Kovacic D, Vuger T, Kalenic B. Relation between anxiety, depression and locus of control of patients with multiple sclerosis. Mult Scler 2007;13:1065-1067.
27. Burns MN, Siddique J, Fokuo JK, Mohr DC. Comorbid anxiety disorders and treatment of depression in people with multiple sclerosis. Rehabil Psychol 2010;55:255-262.
28. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
29. Zigmond AS, Snaith R P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
30. Goldberg D, Williams P. A user's guide to the General Health Questionnaire. Windsor: NFER-Nelson; 1988.
31. Goldberg D. General Health Questionnaire (GHQ-12). Windsor: NFER-Nelson; 1992.
32. Honarmand K, Feinstein A. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler 2009;15:1518-1524.
33. Nicholl CR, Lincoln NB, Francis VM, Stephan TF. Assessment of emotional problems in people with multiple sclerosis. Clin Rehabil 2001;15:657-668.
34. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self-report scales. J Neurol Neurosurg Psychiatr 2005;76:1539-1543.
35. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-396.
36. Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: Spacapan S, Oskamp S, editors. Social psychology of health: Claremont Symposium on Applied Social Psychology. Newbury Park, CA: Sage; 1988, pp. 31-67.
37. Johnson SK, Frederick J, Kaufman M, Mountjoy B. A controlled investigation of bodywork in multiple sclerosis. J Altern Complement Med 1999;5:237-243.
38. Sharrack B, Hughes RA. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler 1999;5:223-233.
39. Wallston KA, Stein MJ, Smith CA. Form C of the MHLC scales: a condition-specific measure of locus of control. J Pers Assess 1994;63:534-553.
40. Wallston KA. The validity of the Multidimensional Health Locus of Control Scales. J Health Psychol 2005;10:623-631.
41. Domenech C, Thornton EW, Young CA, Rigby SA, Tedman, S. Development of a self-efficacy scale for people with multiple sclerosis. Mult Scler 1999;5:S144.
42. Noy S, Achiron A, Gabbay U, Barak Y, Rotstein Z, Laor N, Sarova-Pinhas I. A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry 1995;36:390-395.
43. Riazi A, Thompson AJ, Hobart JC. Self-efficacy predicts self-reported health status in multiple sclerosis. Mult Scler 2004;10:61-66.
44. Motl RW, Snook EM. Physical activity, self-efficacy, and quality of life in multiple sclerosis. Ann Behav Med 2008;35:111-115.
45. Cameron O. Understanding comorbid depression and anxiety. Psychiatric Times 2007;24:14.
46. Roy-Byrne P P, Stang P, Wittchen HU, Ustun B, Walters EE, Kessler RC. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br J Psychiatry 2000;176:229-235.
47. Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002;59:674-678.
48. Aarsland D, Figved N. Are anxiety disorders undertreated in patients with multiple sclerosis? Nat Clin Pract Neurol 2007;3:372-373.
49. Gilchrist AC, Creed FH. Depression, cognitive impairment and social stress in multiple sclerosis. J Psychosom Res 1994;38:193-201.
50. Julian LJ, Arnett PA. Relationships among anxiety, depression, and executive functioning in multiple sclerosis. Clin Neuropsychol 2009; 23:794-804.
51. Borkovec TD, Ruscio AM. Psychotherapy for generalized anxiety disorder. J Clin Psychiatry 2001;62 Suppl 11:37-42; discussion 43.